Foreign Aid
Jump to navigation
Jump to search
The Human Cost of Cutting Global Health Aid
For more than two decades, U.S. foreign assistance—especially through USAID, PEPFAR, and related global health programs—has played a major role in reducing preventable deaths across low- and middle-income countries. The articles reviewed here describe a broad and consistent pattern: international health aid has helped expand vaccination, HIV treatment, tuberculosis diagnosis, maternal health care, child survival programs, family planning, nutrition, and emergency humanitarian response. When these programs are abruptly reduced or withdrawn, the consequences are not abstract budget changes. They can be measured in lives lost, infections left untreated, children unvaccinated, mothers without safe delivery care, and health systems suddenly forced to absorb responsibilities they are not prepared or financed to carry.
The central article, “Evaluating the impact of two decades of USAID interventions and projecting the effects of defunding on mortality up to 2030,” argues that USAID-supported programs helped prevent tens of millions of deaths between 2001 and 2021. Its projection that more than 14 million additional deaths could occur by 2030 if cuts continue gives the aid debate a stark moral and public-health dimension. The issue is not simply whether foreign aid is generous or politically popular. The issue is whether the world is willing to allow preventable mortality to rise after decades of measurable progress.
A related Lancet Global Health article on humanitarian and development assistance broadens this question beyond USAID alone. It shows that official development assistance as a whole has been deeply connected to mortality reductions in many vulnerable countries. This matters because USAID cuts do not happen in isolation. When the United States reduces aid at the same time that European governments and other donors scale back, recipient countries may face a compounded crisis. Reuters’ reporting on possible U.S. and European aid cuts causing up to 22.6 million additional deaths worldwide reinforces this broader danger. The problem is not just one donor exiting one program; it is the possibility of a synchronized retreat from global health financing.
The disease-specific studies show why the mortality effects could be so large. HIV programs are especially vulnerable because treatment must be continuous. Articles in The Lancet HIV, eClinicalMedicine, The Guardian, AP, UNAIDS, and Nature all describe the danger of cuts to HIV funding, particularly through PEPFAR. If people lose access to antiretroviral therapy, the consequences include rising viral loads, increased transmission, more AIDS-related deaths, and the possible erosion of decades of progress. The Lancet HIV modeling study projects that a major international HIV funding crisis could lead to millions of additional infections and large numbers of HIV-related deaths by 2030. The eClinicalMedicine study on the PEPFAR funding freeze shows that even temporary interruptions in seven sub-Saharan African countries could produce measurable excess deaths and infections. These articles together make a crucial point: HIV programs cannot simply pause and restart without harm. Interruptions themselves can become deadly.
Tuberculosis presents a similar warning. The Lancet Global Health study on donor funding reductions and tuberculosis, the PLOS Medicine study on the household economic burden of TB, and the WHO feature on 2025 funding cuts all show that TB control depends on diagnosis, treatment continuity, and public-health infrastructure. When funding falls, fewer people are screened, diagnosed, and treated. That can increase transmission and worsen drug resistance. The PLOS Medicine article adds another dimension: aid cuts do not only increase disease burden; they can also increase household poverty. Families facing TB may lose income, pay for transportation or private care, and experience catastrophic health costs. In this way, donor cuts can create a cycle in which illness worsens poverty and poverty worsens illness.
Maternal and child health are also central to the projected mortality impact. The Health Policy and Planning article on USAID withdrawal in six African countries estimates a sharp increase in maternal deaths under a no-substitution scenario. This is especially important because maternal mortality is often closely tied to basic health-system capacity: trained birth attendants, emergency obstetric care, transportation, supplies, and referral systems. Oxfam’s analysis of under-five deaths, the Gates Foundation Goalkeepers report, and the MSF statement on U.S. support for Gavi all emphasize the child-survival side of the crisis. If vaccine programs, nutrition services, malaria prevention, and basic child health services are cut, children are among the first to die. These deaths are particularly tragic because many are preventable with relatively inexpensive interventions.
Several articles focus not just on the biological or medical effects of aid cuts, but on the political and ethical meaning of abrupt withdrawal. The Lancet commentary “Global health after USAID cuts” and the article “Legitimate expectations and the abrupt cessation of US aid: a human rights issue?” raise questions about responsibility. If donor countries fund essential health programs for years, health systems and communities begin to rely on them. Governments hire workers, patients begin treatment, clinics structure services, and supply chains are built around expected support. Abruptly ending that support is therefore different from gradually transitioning programs to domestic control. Planned transition can be responsible. Sudden withdrawal can be destabilizing and deadly.
The KFF analysis of the foreign aid freeze explains why replacement funding is difficult. Many low- and middle-income countries depend heavily on U.S. support for HIV, TB, malaria, maternal health, and other core services. Other donors may not have the money, political will, or infrastructure to fill the gap. Domestic governments may want to assume more responsibility but lack the fiscal space to do so quickly. This is why many of the studies use no-substitution or partial-substitution scenarios: they reflect the reality that when USAID or PEPFAR funds disappear, there may be no immediate substitute.
The Center for Global Development articles help translate this into practical terms by asking how many lives U.S. foreign aid saves and updating estimates of lives lost from USAID cuts. These analyses are important because they connect mortality projections to actual spending and obligations. They also help show that the benefits of aid are not vague. Programs for HIV treatment, vaccines, malaria prevention, TB control, humanitarian relief, and maternal-child health have measurable outputs and measurable mortality effects.
Together, these articles support one central conclusion: global health aid has been one of the most effective tools for reducing preventable death, and cutting it abruptly is likely to produce severe human consequences. The projected death toll varies by model, disease area, time period, and assumption, but the direction of the evidence is consistent. Reduced funding means fewer services. Fewer services mean more untreated disease, more infections, more unsafe births, more unvaccinated children, and more preventable deaths.
The debate over foreign aid is often framed as a budgetary or political question, but these articles show that it is also a question of life and death. A responsible approach to aid reform would require careful transition planning, protection of the highest-impact health programs, bridge financing, and coordination with affected countries. Abrupt defunding, by contrast, risks reversing decades of progress and transferring the burden to the poorest communities in the world. The evidence from these articles suggests that the cost of such cuts would not only be measured in dollars saved, but in millions of lives lost.
Evaluating the impact of two decades of USAID interventions and projecting the effects of defunding on mortality up to 2030
| Daniella Medeiros Cavalcanti et al. | The Lancet | June 30, 2025
This retrospective impact evaluation and forecasting analysis estimates the mortality effects of USAID-supported interventions from 2001 to 2021 and projects the consequences of USAID defunding through 2030. The study argues that USAID programs helped prevent tens of millions of deaths in low- and middle-income countries and warns that abrupt cuts could produce more than 14 million additional deaths by 2030, including millions of children under five.
Impact of two decades of humanitarian and development assistance and the projected mortality consequences of current defunding to 2030
| Andrea Ferreira da Silva et al. | The Lancet Global Health | 2026
This article expands the USAID-focused question to broader official development assistance, evaluating the mortality impact of humanitarian and development aid across vulnerable countries over two decades. It models the potential human cost of current defunding trends and estimates that millions of excess deaths could occur by 2030 if aid reductions continue.
Aid cut, lives lost: estimating the impact of USAID’s withdrawal on maternal mortality in six African countries
| Matthew Cummins | Health Policy and Planning | March 10, 2026
This study models the effect of USAID withdrawal on maternal mortality in Burkina Faso, Central African Republic, Chad, Mali, Niger, and Nigeria. Using a no-substitution scenario, it projects that sudden cuts to USAID health funding could increase maternal deaths by about 45 percent among populations in humanitarian need.
Effects of reductions in US foreign assistance on HIV, tuberculosis, family planning, and maternal and child health
| John Stover et al. | The Lancet Global Health | October 2025
This modeling study estimates the health consequences of reducing U.S. foreign assistance from 2025 to 2030 across HIV, tuberculosis, family planning, and maternal and child health programs. It is one of the closest disease-area companions to the USAID mortality study because it translates aid reductions into projected deaths, infections, and service disruptions.
Impact of an international HIV funding crisis on HIV infections and mortality in low-income and middle-income countries
| Debra ten Brink et al. | The Lancet HIV | March 26, 2025
This modeling study examines how international HIV funding cuts could affect HIV infections and HIV-related deaths in low- and middle-income countries through 2030. It projects that major donor reductions could lead to millions of additional HIV infections and hundreds of thousands to millions of additional HIV-related deaths.
The potential impact of reductions in international donor funding on tuberculosis in low-income and middle-income countries
| Rebecca A. Clark et al. | The Lancet Global Health | 2025
This tuberculosis-focused modeling study evaluates how reductions in international donor funding could affect TB incidence and mortality in low- and middle-income countries. It is especially relevant to the USAID defunding literature because TB programs in many countries depend heavily on external financing, and service disruption can quickly reverse gains in diagnosis and treatment.
The potential impact of reduced international donor funding on the household economic burden of tuberculosis in low- and middle-income countries
| Allison Portnoy et al. | PLOS Medicine | February 20, 2026
This article models how donor funding reductions could increase the household economic burden of tuberculosis in low- and middle-income countries. Rather than focusing only on deaths and cases, it connects aid cuts to catastrophic costs for families, showing how health financing shocks can worsen both disease outcomes and poverty.
Tracking development assistance for health, 1990–2030: historical trends, recent cuts, and outlook
| Angela E. Apeagyei et al. | The Lancet | July 15, 2025
This article tracks development assistance for health from 1990 to 2030, combining historical spending data with projections after recent donor cuts. It provides the broader financing context for USAID and ODA defunding studies by showing how global health aid has changed over time and how current reductions could reshape health systems.
We Can’t Stop at Almost: 2025 Goalkeepers Report
| Gates Foundation | Gates Foundation | December 3, 2025
This report warns that global health funding cuts could reverse decades of progress in child survival and other health outcomes. It emphasizes high-impact health investments, especially for maternal and child health, and frames aid reductions as a direct threat to continued progress against preventable deaths.
A child under five could die every forty seconds by 2030 due to U.S. aid cuts, Oxfam analysis finds
| Oxfam | Oxfam International | January 15, 2026
This Oxfam analysis uses projected aid-cut mortality estimates to highlight the potential impact on children under five. It argues that U.S. aid reductions could contribute to a severe rise in preventable child deaths by 2030 and presents the issue as both a humanitarian and policy failure.
2025 Global AIDS Update: AIDS, Crisis and the Power to Transform
| UNAIDS | Joint United Nations Programme on HIV/AIDS | July 2025
This UNAIDS report examines the global HIV response amid a major international funding crisis. It warns that sudden donor cuts could threaten decades of progress against HIV/AIDS, while also documenting how countries and communities are trying to adapt to protect treatment, prevention, and testing services.
The impact of 2025 funding cuts on TB services
| World Health Organization | World Health Organization | 2025
This WHO feature summarizes early evidence on how 2025 funding cuts are affecting tuberculosis services, especially in countries dependent on both USAID and Global Fund support. It discusses disruptions to TB diagnosis and treatment and connects observed service impacts with modeling studies on future TB deaths and cases.
Global health after USAID cuts
| Daniel Krugman et al. | The Lancet | December 2025
This Lancet commentary responds to the health implications of USAID cuts and discusses how global health institutions should interpret and react to abrupt donor withdrawal. It is useful as a policy and interpretation companion to mortality-modeling studies, especially for understanding assumptions, ethics, and response strategies.
Legitimate expectations and the abrupt cessation of US aid: a human rights issue?
| Chris Beyrer | The Lancet | January 3, 2026
This article examines the abrupt cessation of U.S. aid through a human-rights framework, asking whether populations and programs had legitimate expectations of continued support. It broadens the discussion beyond mortality projections to questions of reliance, responsibility, and legal or ethical duties when aid is suddenly withdrawn.
Projected costs to human life of ODA defunding and implications for aid transitions in LMICs
| The Lancet Global Health | The Lancet Global Health | 2026
This commentary discusses the projected human costs of official development assistance defunding and the implications for aid transitions in low- and middle-income countries. It is useful for framing the difference between planned transitions away from aid dependence and abrupt cuts that leave health systems without replacement financing.
USAID cuts may cause 14 million more deaths in next five years, study says
| Kelsey Ables | The Washington Post | July 1, 2025
This news article summarizes the Lancet USAID mortality study for a general audience, highlighting the estimate that USAID programs saved about 91 million lives over two decades and that cuts could cause more than 14 million additional deaths by 2030. It is useful as an accessible overview of the study’s findings and policy relevance.
US and European aid cuts could result in 22.6 million deaths worldwide, study finds
| Reuters | Reuters | November 17, 2025
This Reuters article reports on research estimating that cuts by the United States and European donors could cause up to 22.6 million additional deaths worldwide by 2030. It places the USAID cuts in a broader donor-country context and emphasizes the compounded impact of simultaneous aid reductions by multiple governments.
The UN warns millions will die by 2029 if US funding for HIV programs isn’t replaced
| Associated Press | Associated Press | July 10, 2025
This Associated Press article summarizes UNAIDS warnings that millions could die if U.S. HIV funding is not replaced. It connects the funding crisis to PEPFAR, treatment access, and the broader risk that progress against AIDS could stall or reverse.
| Kat Lay | The Guardian | March 26, 2025
This Guardian article summarizes a Lancet HIV modeling study projecting that international aid cuts could cause up to 2.9 million additional HIV-related deaths by 2030. It is a useful journalistic companion for explaining the HIV-specific consequences of cuts to PEPFAR and other donor-funded programs.
25 million deaths: what could happen if the US ends global health funding
| Smriti Mallapaty | Nature | April 17, 2025
This Nature news article summarizes modeling estimates of the potential global health consequences if the United States ends global health funding. It discusses projections that roughly 25 million people could die over 15 years if U.S. support for tuberculosis, HIV, family planning, and maternal and child health programs is withdrawn.
The impact of the PEPFAR funding freeze on HIV deaths and infections: a mathematical modelling study of seven countries in sub-Saharan Africa
| Jan A. C. Hontelez et al. | eClinicalMedicine | 2025
This modeling study estimates the mortality and infection consequences of the PEPFAR funding freeze in seven sub-Saharan African countries. It finds that even temporary interruptions to U.S.-supported HIV programs could cause tens of thousands of excess HIV deaths and new infections, showing how quickly service disruption can reverse gains from long-term HIV investment.
“Massive retrogression”: USAID cuts affect global morbidity and mortality
| Haneen Rilkoff | The BMJ | March 28, 2025
This BMJ article reports on the health consequences of USAID cuts, describing the reductions as a major setback for global morbidity and mortality. It is useful as a medical-journal news source that connects abrupt U.S. aid reductions to disruptions in health services, disease control, and preventable deaths.
Relief agencies in shock as Trump cuts 90% of USAID funding
| Owen Dyer | The BMJ | March 4, 2025
This BMJ article reports on the shock among humanitarian and health organizations after the Trump administration cut about 90 percent of USAID funding. It provides early context for the operational collapse behind later mortality projections, including terminated awards, halted services, and uncertainty for agencies dependent on U.S. aid.
Surviving the aid cuts: how countries are sustaining health services
| Simon Williams | The BMJ | September 23, 2025
This BMJ feature examines how countries affected by foreign aid cuts are trying to keep health services operating despite sudden funding losses. It is useful for understanding the adaptation side of the crisis, including domestic financing, regional cooperation, supply-chain changes, and efforts to preserve essential public health infrastructure.
The Trump Administration’s Foreign Aid Freeze and Global Health: The Biggest Gaps Left on the Donor Landscape
| Jennifer Kates, Adam Wexler, and Anna Rouw | KFF | March 6, 2025
This KFF analysis examines the donor gaps created by the Trump administration’s foreign aid freeze and the attempted dismantling of USAID. It shows how heavily many low- and middle-income countries depend on U.S. support for global health, especially HIV, tuberculosis, and malaria programs, and explains why other donors may be unable to fully replace the lost funding.
How Many Lives Does US Foreign Aid Save?
| Charles Kenny and Justin Sandefur | Center for Global Development | March 15, 2025
This Center for Global Development analysis estimates how many lives are saved each year by U.S. foreign assistance. It focuses on major life-saving categories such as HIV/AIDS, Gavi-supported vaccines, tuberculosis, malaria, and humanitarian relief, and provides a useful methodological companion to studies projecting deaths from aid cuts.
Update on Lives Lost from USAID Cuts
| Charles Kenny and Justin Sandefur | Center for Global Development | December 16, 2025
This follow-up analysis updates earlier estimates of lives lost from USAID cuts using newer financial data and information on spending declines. It estimates that the mortality impact of reduced outlays and obligations could be severe, and it helps bridge the gap between broad Lancet-style projections and budget-based estimates of lives lost.
Impact of US funding cuts on the global HIV response
This UNAIDS resource hub tracks the effect of U.S. funding cuts on HIV services across affected countries. It documents disruptions to HIV treatment, prevention, community-led services, and national HIV responses, making it a useful source for country-level examples behind broader projections of excess HIV infections and AIDS-related deaths.
US decision to end support for Gavi puts millions of children’s lives at risk
| Doctors Without Borders/Médecins Sans Frontières | MSF Access Campaign | March 27, 2025
This MSF statement warns that ending U.S. support for Gavi could leave tens of millions of children without routine vaccinations and could contribute to more than one million child deaths. It is especially relevant to the child mortality side of the aid-cut debate because it links vaccine financing losses to preventable deaths from diseases such as measles, pneumonia, and diphtheria.
